Enzolytics Inc (ENZC)

[bigtalan]

One thing to keep in mind , who holds the patents hopefully we will get news that will clear up what is going on. glta
Two Patent License Agreements
On November 30, 2020, Biogenysis, Inc., a wholly-owned subsidiary of Enzolytics, Inc., entered into a Patent License
Agreement with Bioclonetics in order to license the U.S. Provisional Patent Application No. 63/078,482, filed September 15,
2020, entitled NOVEL HIV-BINDING PEPTIDES for treating, preventing and reducing the risks of HIV, including all patents
issuing therefrom and any foreign counterparts thereof.
Also on November 30, 2020, Virogentics, Inc., a wholly-owned subsidiary of Enzolytics, Inc., entered into a Patent License
Agreement with the Zhabilov Trust in order to license the U.S. Patent No. 7,479538, entitled Irreversibly - Inactivated
pepsinogen fragment and Pharmaceutical composition the same for detecting preventing and treating HIV; U.S. Patent No.
8,066982, Irreversibly - Inactivated pepsinogen fragment and Pharmaceutical composition compressing the same for
detecting preventing and treating HIV, including all patents issuing therefrom and any foreign counterparts thereof.